冠脉介入治疗时期氯吡格雷抵抗的认识与思考——抓住本质,全面获益

被引:8
作者
马颖艳
韩雅玲
机构
[1] 沈阳军区总医院心内科
关键词
氯吡格雷; 抵抗; 基因多态性;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
急性冠脉综合征已步入药物洗脱支架进行血运重建的时期,双联抗血小板治疗是接受PCI治疗的常规手段。临床发现部分患者不能从氯吡格雷治疗中获益,存在氯吡格雷抵抗的现象。笔者就氯吡格雷抵抗的发生机制、临床意义及治疗对策进行描述,反映相关研究的趋势和方向,为未来更优化抗血小板治疗提出一种策略。
引用
收藏
页码:49 / 50+67 +67
页数:3
相关论文
共 8 条
[1]   细胞色素P450 3A4 894C>T位点基因多态性与氯吡格雷抵抗的关系 [J].
韩雅玲 ;
麦晓燕 ;
李毅 ;
张效林 ;
郭亮 ;
闫承慧 .
解放军医学杂志, 2008, (08) :939-942
[2]   Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study [J].
Collet, Jean-Philippe ;
Hulot, Jean-Sebastien ;
Pena, Anna ;
Villard, Eric ;
Esteve, Jean-Baptiste ;
Silvain, Johanne ;
Payot, Laurent ;
Brugier, Delphine ;
Cayla, Guillaume ;
Beygui, Farzin ;
Bensimon, Gilbert ;
Funck-Brentano, Christian ;
Montalescot, Gilles .
LANCET, 2009, 373 (9660) :309-317
[3]   Relation of Genetic Polymorphisms in the Cytochrome P450 Gene With Clopidogrel Resistance After Drug-Eluting Stent Implantation in Koreans [J].
Lee, Jung Myung ;
Park, Sungha ;
Shin, Dong-Jik ;
Choi, Donghoon ;
Shim, Chi Young ;
Ko, Young-Guk ;
Kim, Jung-Sun ;
Shin, Eun-Soon ;
Chang, Chong Won ;
Lee, Jong-Eun ;
Jang, Yangsoo .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (01) :46-51
[4]   Association of platelet responsiveness with clopidogrel metabolism: Role of compliance in the assessment of "resistance" [J].
Serebruany, Victor ;
Cherala, Ganesh ;
Williams, Craig ;
Surigin, Serge ;
Booze, Christopher ;
Kuliczkowski, Wiktor ;
Atar, Dan .
AMERICAN HEART JOURNAL, 2009, 158 (06) :925-932
[5]   Can We Override Clopidogrel Resistance? [J].
Pena, Ana ;
Collet, Jean-Philippe ;
Hulot, Jean-Sebastien ;
Silvain, Johanne ;
Barthelemy, Olivier ;
Beygui, Farzin ;
Funck-Brentano, Christian ;
Montalescot, Gilles .
CIRCULATION, 2009, 119 (21) :2854-2857
[6]   Calcium-Channel Blockers Reduce the Antiplatelet Effect of Clopidogrel [J].
Siller-Matula, Jolanta M. ;
Lang, Irene ;
Christ, Guenter ;
Jilma, Bernd .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (19) :1557-1563
[7]  
Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents.[J].Dietmar Trenk;Willibald Hochholzer;Martin F. Fromm;Ligia-Emilia Chialda;Andreas Pahl;Christian M. Valina;Christian Stratz;Peter Schmiebusch;Hans-Peter Bestehorn;Heinz Joachim Büttner;Franz-Josef Neumann.Journal of the American College of Cardiology.2008, 20
[8]  
Lack of Evidence of a Clopidogrel–Statin Interaction in the CHARISMA Trial.[J].Jacqueline Saw;Danielle M. Brennan;Steven R. Steinhubl;Deepak L. Bhatt;Koon-Hou Mak;Keith Fox;Eric J. Topol.Journal of the American College of Cardiology.2007, 4